BFRI (STOCKS)
Biofrontera Inc. Common Stock
$1.050000
+0.020000 (+1.94%)
Prev close: $1.030000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Hermann Lübbert
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $12.17M
- Employees
- 93
- P/E (TTM)
- -0.88
- P/B (TTM)
- 1.14
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $41.71M |
| Benefits Costs and Expenses | $52.22M |
| Costs And Expenses | $53.05M |
| Nonoperating Income/Loss | $837.00K |
| Operating Expenses | $53.05M |
| Selling, General, and Administrative Expenses | $37.75M |
| Research and Development | $3.72M |
| Other Operating Expenses | $11.58M |
| Operating Income/Loss | -$11.35M |
| Income/Loss Before Equity Method Investments | -$10.51M |
| Income/Loss From Continuing Operations After Tax | -$10.54M |
| Income/Loss From Continuing Operations Before Tax | -$10.51M |
| Income/Loss From Equity Method Investments | $2.00K |
| Income Tax Expense/Benefit | $25.00K |
| Net Income/Loss | -$10.54M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$10.54M |
| Net Income/Loss Available To Common Stockholders, Basic | -$10.54M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.04 |
| Diluted Earnings Per Share | -$1.04 |
| Basic Average Shares | 10,171,921 |
| Diluted Average Shares | 10,171,921 |
| Assets | $28.56M |
| Current Assets | $18.08M |
| Inventory | $1.43M |
| Other Current Assets | $16.66M |
| Noncurrent Assets | $10.48M |
| Fixed Assets | $2.16M |
| Intangible Assets | $2.65M |
| Other Non-current Assets | $5.67M |
| Liabilities | $18.08M |
| Current Liabilities | $11.90M |
| Wages | $2.81M |
| Other Current Liabilities | $9.09M |
| Noncurrent Liabilities | $6.19M |
| Equity | $10.48M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $10.48M |
| Liabilities And Equity | $28.56M |
| Net Cash Flow From Operating Activities | -$13.36M |
| Net Cash Flow From Operating Activities, Continuing | -$13.36M |
| Net Cash Flow From Investing Activities | $3.00M |
| Net Cash Flow From Investing Activities, Continuing | $3.00M |
| Net Cash Flow From Financing Activities | $10.85M |
| Net Cash Flow From Financing Activities, Continuing | $10.85M |
| Net Cash Flow | $487.00K |
| Net Cash Flow, Continuing | $487.00K |
| Comprehensive Income/Loss | -$10.54M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$10.54M |
| Other Comprehensive Income/Loss | $0.00 |